Key Highlights: Implications: The new cGMP/US FDA/EU-compliant suite at Gland’s Visakhapatnam JNPC site, adding ~1,400 kg/year of sterile API capacity, should help both companies capture m...
Key Highlights: Implications: The collaboration gives Arica Pharmaceutical a potential growth catalyst as it moves beyond its core anti-diabetic, neurosciences, and cardiovascular portfolio...
